Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Pilot Trial on Safety and Feasibility of Argatroban As Anticoagulant in Patients with Extracorporeal Membrane Oxygenation (ECMO)

NCT05226442 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT05226442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05226442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Pilot Trial on Safety and Feasibility of Argatroban As Anticoagulant in Patients with Extracorporeal Membrane Oxygenation (ECMO)
Lead sponsor
Medical University of Vienna
Phase
Phase 2/3
Overall status
Completed
Start date
December 1, 2021
Completion date
July 7, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants and bleeding disorders, extracorporeal membrane oxygenation complication